Nova Patents
AT214602T

Antitumor agent potentiator comprising il-6 antagonist

Abstract

A resistance tumour agent, 羰 platinum and other platinum compounds and mitomycin C and equal with the anti-tumour agent function potentiator of the enhanced function of the platinum, comprising a white blood cell element (6) IL-6 antagonists to the IL-6 antibody and IL-6 receptor antibody, gp130 antibody and a.

Term

No projected expiry on record.

  1. Priority
  2. Filed
  3. Granted
  4. Today

25 members in 12 offices

This recordMember, by publication datePriority claim2 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
34042594JapanA
9502769JapanW

Members25

Family members, oldest first
DocumentOfficeKind
CA2209124A1CanadaA1
WO9620728A1World Intellectual Property Organization (WIPO)A1
AU4356896AAustraliaA
JPH08231433AJapanA
EP0800829A1European Patent Office (EPO)A1
CN1174507AChinaA
HK1001512A1Hong Kong, ChinaA1
AU704723B2AustraliaB2
EP0800829A4European Patent Office (EPO)A4
US6086874AUnited States of AmericaA
KR100252743B1Republic of KoreaB1
CN1075387CChinaC
EP0800829B1European Patent Office (EPO)B1
AT214602TThis recordAustriaT
ATE214602T1AustriaT1
DE69525971D1GermanyD1
ES2170815T3SpainT3
DE69525971T2GermanyT2
JP2008063344AJapanA
JP4079461B2JapanB2
CA2209124CCanadaC
JP4812736B2JapanB2
EP0800829B2European Patent Office (EPO)B2
ES2170815T5SpainT5
DE69525971T3GermanyT3